Module 2: Quality and Quality Measures The degree to which health services for individuals and populations increase the likelihood of desired health outcomes.

Slides:



Advertisements
Similar presentations
Patient Safety and Quality of Care: Role of the Compliance Professional Harvey V. Fineberg, M.D., Ph.D. Sixth Annual National Congress on Health Care Compliance.
Advertisements

PAYING FOR PERFORMANCE In PUBLIC HEALTH: Opportunities and Obstacles Glen P. Mays, Ph.D., M.P.H. Department of Health Policy and Administration UAMS College.
Closing the Quality Chasm: Opportunities and Strategies for Moving Toward a High Performance Health System Karen Davis President The Commonwealth Fund.
1 Drafting a Standard n Establish the requirements n Agree the process n Draft the Standard n Test the Standard n Implement the Standard.
Dr. Hamda Qotba, M.D,MFPH,FFPH
An Overview of the Alberta Screening & Prevention Initiative Improvement Facilitator Training Session 1 Day 1.
Understanding Those Who Do and Do Not Plan to Get Colorectal Cancer (CRC) Screening Costanza ME, White MJ, Stark JR, Stoddard AM, Avrunin JS, Luckmann.
The National Comprehensive Cancer Control Program (NCCCP): Current Progress and Future Action Temeika L. Fairley, Epidemiologist Comprehensive Cancer Control.
Public Health Perspective on Radon Control in Ireland Dr. Ina Kelly Specialist Registrar in Public Health Medicine Health Service Executive Department.
Funded by HRSA HIV/AIDS Bureau Selecting an Indicator & Collecting Performance Data Barbara M Rosa, RN-C, MS.
Department of Health and Human Services Measuring Clinical Lab Ordering Quality: Theory and Practice Steven M. Asch MD MPH VA, RAND, UCLA April 29, 2005.
Eva Stensland MD, PhD National Network of Competence for Medical Quality Registries How to evaluate quality in medicine.
In the name of Allah. Development and psychometric Testing of a new Instrument to Measure Affecting Factors on Women’s Behaviors to Breast Cancer Prevention:
Haley Hyde Jessica Fordham Jena Hamm  Colorectal cancer is a leading cause of cancer related deaths every year.  150,000 Americans will be diagnosed.
Cancer Program Fewer Montanans experience late stage cancer. Fewer Montanans die of cancer. Metrics Biannual percent of Montanans who are up-to-date with.
An Overview of the Alberta Screening & Prevention Initiative.
How to Measure Quality of Care in Family Practice Using Administrative Data Alan Katz, Ruth-Ann Soodeen, Bogdan Bogdanovic, Carolyn De Coster, and Dan.
Azara Proprietary & Confidential Overview June 2014 Improving Patient Outcomes through Data.
Criteria and Standard.
Quality in Laboratory Medicine Conference Business Case for Quality Recognizing Excellence in Practice Presented to the Institute for Quality in Laboratory.
Health Literacy: Tools You Can Use
VHA INNOVATION PROGRAM Innovation #391 Phonak Teleaudiology VHA ISB Business Case September 25, 2013.
InteractiveMedicalPlanner.com. IMPAct: Interactive Medical Planner ACTing on your health IMPAct is a website application that creates an interactive medical.
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
1 Lecture 2: Types of measurement Purposes of measurement Types and sources of data Reliability and validity Levels of measurement Types of scale.
Medicare Annual Wellness Exam Presented by: Susan Duden, CPC. March 24, 2012.
Chart Reviews Improvement Facilitator Training Session 1 Day 2.
Journal Club/September 24, Swing et al. Television and video game exposure and the development of attention problems. Pediatrics 2010;126:
Asthma Disparities – A Focused Examination of Race and Ethnicity on the Health of Massachusetts Residents Jean Zotter, JD Director, Asthma Prevention and.
Influenza Vaccination Campaign 2003 Dr. Michael Koller QI Director for Primary Care.
SchusterView Graph # 1 OUTLINE FOR TODAY’S TALK Quality of Care: Definitions Who Uses Quality Assessment Information Quality Measurement Methods Challenges.
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
Dr K N Prasad Community Medicine
Patient Wellness Handout. Institute of Medicine  The Institute of Medicine (IOM) released “To Err is Human” and “Crossing the Quality Chasm” which identify.
HW215: Models of Health & Wellness Unit 7: Health and Wellness Models Geo-political Influences.
Outcome research 1 Outcome/ instruments selection Wei-Chu Chie Preventive Medicine.
Data Sources-Cancer Betsy A. Kohler, MPH, CTR Director, Cancer Epidemiology Services New Jersey Department of Health and Senior Services.
Quality in Health Care Dr. Abdul Sattar Khan MBBS, MPH, MCPS, DCHM, MRCGP (UK), FRIPH (UK) Assistant Professor Family Medicine Department
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
1 The Effect of Primary Health Care Orientation on Chronic Illness Care Management Julie Schmittdiel, Ph.D., Stephen M. Shortell, Ph.D., Thomas Rundall,
Reducing Health Disparities Through Research & Translation Programs Francis D. Chesley, Jr., M.D. Francis D. Chesley, Jr., M.D. Director, Office of Extramural.
Healthy People 2010 Focus Area 3 Cancer Progress Review October 16, 2002.
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
Impact of Perceived Discrimination on Use of Preventive Health Services Amal Trivedi, M.D., M.P.H. John Z. Ayanian, M.D., M.P.P. Harvard Medical School/Brigham.
Georgia Comprehensive Cancer Control Program 3/10/2015 Program Monitoring and Evaluation Activities Short-Term Outcomes Long-Term Outcomes Intermediate.
Clinical Audit Identify areas of excellence and areas for improvement Ensures that current practice meets an expected standard.
Composite Approaches for Electronic Clinical Quality Measures January 17, 2014.
Component 1: Introduction to Health Care and Public Health in the U.S. 1.9: Unit 9: The evolution and reform of healthcare in the US 1.9c: Quality Indicators.
Screening – a discussion in clinical preventive medicine Galit M Sacajiu MD MPH.
Session 2: Developing a Comprehensive M&E Work Plan.
Chapter 5 Population Health Quality and Safety Learning Objectives 1. Explain why it is difficult to monitor healthcare quality and safety at the population.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
PRAGMATIC Study Designs: Elderly Cancer Trials
Cancer prevention and early detection
Clinical Epidemiology
Colorectal Cancer Screening Guidelines
USING NATIONAL GUIDELINES FOR SCREENING, TREATMENT, AND FOLLOW-UP
NYSDOH AIDS Institute Quality of Care Program eHIVQUAL
Quality Improvement and EBM
Quality Health Care Nursing 870
Evidence of a Program's Effectiveness in Improving Colorectal Cancer Screening Rates in Federally Qualified Health Centers Robert L. Stephens, PhD, MPH1;
Definition of Cancer Screening
Tara Kiran1,2, Alex Kopp2, Rick Glazier1,2
University of Witwatersrand, Johannesburg, South Africa
Competencies and Outcomes in Therapeutic Recreation Chapter 1
QUALITY IMPROVEMENT BASICS
Assessment 101 Zubair Amin MD MHPE.
Standard 3.1 Patient Navigation Process
Citation: Cancer Care Ontario
Dr Timothy Armstrong Coordinator
Presentation transcript:

Module 2: Quality and Quality Measures The degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge. Source: Crossing the Quality Chasm: A New Health System for the 21st Century. Institute of Medicine, Definition of Quality

Types of Measures in Health Care Quality (Donabedian) Structure Process Outcome

Dimensions of Quality Safety Effectiveness Patient-Centeredness Timeliness Efficiency Equity

Criteria for a Good Quality Measure ( National Quality Forum ) Importance Scientific Acceptability Useable Feasible

Let’s walk one of your examples down the trail and visit these criteria.

Importance to Measure and Report Addresses –1) accepted health goal, or –2) high impact area Large numbers, leading cause of morbidity or mortality. Significant resource utilization. High severity. Patient/societal consequences. Associated with Quality Problems and Opportunities for Improvement

Importance to Measure & Report (Continued) Focus is –An outcome (morbidity, mortality, function, QoL); or –An intermediate outcome (HbA1c) with causal linkage to outcome; or –A process with evidence; or –A structure consistent delivery of effective care or access; or –A patient experience linked to outcomes, values or preferences; or –Access to effective care; or –Efficiency

Scientific Acceptability of Measure Properties Potential for consistent implementation. Reliable (Test-retest at population level). Valid (measures what it is supposed to). –criterion, construct, predictive, content, and face. Exclusions specified and justified. Risk adjusted as appropriate. Ability to detect statistically and clinically significant differences over time, between sites. Ability to identify disparities.

Usability Understandable and useful to intended audiences. Aligned or in harmony with other measures in use. Adds value to existing measures.

Feasible Routinely generated as part of care process. Available electronically. Exclusions should not require additional data sources. Minimum but understood susceptibility to errors. Data collection strategy feasible.

What makes for a good list of indicators? Pareto Principle: Law of the Vital Few Comprehensive Measurement—List of indicators tap into all of the required dimensions. –Structure –Process –Outcome Donabedian

What about combining individual indicators? Composites and Bundles All-or-none scoring. –Patient meets all indicators in the list (yes, no, NA). Patient average method. –Number of indicators in the list that the patient meets. Indicator average. –The average of indicators calculated separately. Notes: see Reeves DR et al. Combining multiple indicators of clinical quality: An evaluation of different analytic approaches. Medical Care 2007;45(6):

An example from the Veterans Health Administration Earlier Prevention Index IMMUNIZATIONS 1) Persons age 65 or older or at high risk of pneumococcal disease with documentation of ever receiving pneumococcal vaccine. 2) Persons age 65 or older or at high risk of influenza with documentation of receiving influenza vaccine in past year. CANCER SCREENING 3) Persons age 50 or older with documentation of serial fecal occult blood screening in the past year or sigmoidoscopy in the past five years or colonoscopy in past 10 years. 4) Females age with documentation of mammography in past two years. 5) Females age 65 and younger who have not had a hysterectomy with documentation of receiving a Pap smear in the past three years. 6) Males age 50 and older with documentation in the chart, within the past year, of a discussion of options and benefits of prostate cancer screening. TOBACCO CONSUMPTION 7) Persons whose charts document annual screen for use of tobacco products. ALCOHOL CONSUMPTION 8) Persons whose charts document annual screening for problem alcohol consumption using a standardized instrument.

Think—Pair—Share Questions How can you combine these indicators? a.All or none? b.Patient Average? c.Indicator Average? Name two advantages of the indicator average method or the all-or-none method.